Penicillamine
پنیسیلامین
🦴 Musculo-Skeletal SystemChelating agent (copper, cystine)
Market / country: 🇺🇸 USA
Cuprimine (US)
🧮 Dose calculator
Wilson disease · Regimen source: FDA Cuprimine · Dosage and Administration
🛡️ Safety & information
Contraindications
- ⛔ Pregnancy (except Wilson disease or some cystinuria); breastfeeding; prior penicillamine-related aplastic anaemia or agranulocytosis; rheumatoid arthritis with history or evidence of renal insufficiency. FDA Cuprimine · Contraindications
Warnings
- • Fatalities from aplastic anaemia, agranulocytosis, thrombocytopenia, Goodpasture syndrome and myasthenia gravis — urinalysis and CBC twice weekly initially. FDA Cuprimine · Warnings
Formulations
- 250 mg capsule — capsule 🇺🇸 USA FDA Cuprimine · Description
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Cuprimine · CONTRAINDICATIONS
“Except for the treatment of Wilson’s disease or certain patients with cystinuria, use of penicillamine during pregnancy is contraindicated (see WARNINGS ).”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cuprimine · Nursing Mothers
“See CONTRAINDICATIONS .”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cuprimine · Pediatric Use
“The efficacy of CUPRIMINE in juvenile rheumatoid arthritis has not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cuprimine · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drugs.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA019853
- DailyMed (FDA label)FDA Cuprimine
- MedlinePlus (NIH)Penicillamine
- WHO ATC/DDDM01CC01
- Darooyab (Iran)Penicillamine
🇮🇷 Registered in Iran Darooyab · G-1972/Penicillamine
Dosage forms with Iranian generic codes, per Darooyab.
- 08800 · PENICILLAMINE 125MG CAP · کپسول پنیسیلامین ۱۲۵ میلیگرم
- 10996 · PENICILLAMINE 125MG TAB · قرص پنیسیلامین ۱۲۵ میلیگرم
- 01714 · PENICILLAMINE 250MG CAP · کپسول پنیسیلامین ۲۵۰ میلیگرم
- 00967 · PENICILLAMINE 250MG TAB · قرص پنیسیلامین ۲۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cuprimine · DescriptionFDA Cuprimine · Dosage and AdministrationFDA Cuprimine · ContraindicationsFDA Cuprimine · WarningsFDA Cuprimine · SPL approval / marketing categoryFDA Cuprimine · CONTRAINDICATIONSFDA Cuprimine · Nursing MothersFDA Cuprimine · Pediatric UseFDA Cuprimine · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1972/Penicillamine
- Clinical review⚠ Unverified